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Inhalation of zinc oxide (ZnO) particles can 
provoke a number of clinical responses of 
which the best known is metal fume fever 
(Gordon et al. 1992; Kuschner et al. 1995). 
This is accompanied by changes in composi­
tion of broncho  alveolar lavage fluid, includ­
ing early increase in tumor necrosis factor α 
(TNFα) followed by inter  leukin (IL)­8 and 
IL­6, and in numbers of poly  morpho  nuclear 
leukocytes (Blanc et al. 1993; Kuschner et al. 
1995, 1997).
ZnO particles in ambient air arise from 
incinerator emission and from wear and tear 
of vehicle tires (Adachi and Tainosho 2004; 
Bennett and Knapp 1982; Councell et al. 
2004; Horner 1996; Lough et al. 2005). 
Previous studies have demonstrated that expo­
sure to Zn­laden (Zn in its salt and oxidized 
forms) ambient particles contribute to the 
increase in bronchitis and asthma morbidity 
and in lung toxicity (Adamson et al. 2000, 
2003; Hirshon et al. 2008; Pope 1989). It 
is noteworthy that engineered ZnO nano­
particles (< 100 nm in diameter) are cur­
rently being produced in high tonnage (Xia 
et al. 2008). Exposure to these nano  particles 
may occur in occupational, consumer, and 
environmental settings (Stone et al. 2007). 
Inhaled nano  particles can deposit along the 
entire respiratory tract, including airways and 
alveolar regions (Yang et al. 2008). Recent 
in vitro studies have revealed that ZnO nano­
particles had a stronger effect on induction of 
cell damage to human alveolar epithelial cells 
and on IL­8 production from human bron­
chial epithelial cells and aortic endothelial 
cells compared with other metal oxide nano­
particles (Gojova et al. 2007; Park et al. 2007; 
Xia et al. 2008).
IL­8, a member of the CXC chemokine 
family, is an important activator and chemo­
attractant for polymorphonuclear leukocytes 
and has been implicated in a variety of inflam­
matory diseases (Strieter 2002). IL­8 protein is 
secreted at low levels from non  stimulated cells, 
but its production is rapidly induced by a wide 
range of stimuli encompassing proinflamma­
tory cytokines (Kasahara et al. 1991), bacterial 
or viral products (Hobbie et al. 1997; Johnston 
et al. 1998), and cellu  lar stressors (Fritz et al. 
2005; Hirota et al. 2008; Kafoury and Kelley 
2005; Sonoda et al. 1997). Expression of the 
IL‑8 gene is regulated primarily at the level 
of transcription, although contributions by   
post  transcriptional mechanisms such as 
mRNA stabilization have also been demon­
strated (Holtmann et al. 1999, 2001; Roebuck 
1999; Winzen et al. 1999). The IL‑8 gene is 
located on human chromosome 4, q12–21, 
and consists of four exons and three introns. Its 
5´­flanking region contains the usual CCAAT 
and TATA boxlike structures and a number 
of potential binding sites for several inducible 
transcription factors including nuclear factor 
kappa B (NFκB), activator protein­1 (AP­1), 
and CAAT/enhancer­binding protein (C/EBP) 
(Luster 1998; Roebuck 1999; Wu et al. 1997). 
Regulation of IL‑8 gene transcriptional activa­
tion is stimulus and cell­type specific (Brasier 
et al. 1998; Kasahara et al. 1991; Medin and 
Rothman 2006; Roebuck et al. 1999; Strieter 
2002), which requires a functional NFκB 
element in addition to either an AP­1 or a   
C/EBP (NF­IL­6) element under some con­
ditions of transcriptional induction (Strieter 
2002). Unlike the NFκB site, the AP­1 and 
C/EBP sites are not essential for induction but 
are required for maximal gene expression of the 
IL‑8 gene (Hoffmann et al. 2002). Although 
ZnO induces IL­8 expression in bronchial 
epithelial cells and IL­8 plays a critical role 
in the pathogenesis of pulmonary disorders 
(Blanc et al. 1993; Kuschner et al. 1997, 1998; 
Standiford et al. 1993), the mechanisms under­
lying ZnO­induced IL‑8 expression have not 
been well characterized. In this study, we inves­
tigated the regulatory mechanisms underlying 
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Ba c k g r o u n d: Exposure to zinc oxide (ZnO) in environmental and occupational settings 
causes acute pulmonary responses through the induction of proinflammatory mediators such as   
inter  leukin­8 (IL­8).
oB j e c t i v e: We investigated the effect of ZnO nano  particles on IL-8 expression and the underlying 
mechanisms in human bronchial epithelial cells.
Me t h o d s : We determined IL-8 mRNA and protein expression in primary human bronchial epi­
thelial cells and the BEAS­2B human bronchial epithelial cell line using reverse­transcriptase poly­
merase chain reaction and the enzyme­linked immuno  sorbent assay, respectively. Transcriptional 
activity of IL-8 promoter and nuclear factor kappa B (NFκB) in ZnO­treated BEAS­2B cells was 
measured using transient gene transfection of the luciferase reporter construct with or without p65 
constructs. Phosphorylation and degradation of IκBα, an inhibitor of NF­κB, and phosphorylation 
of p65 were detected using immuno  blotting. Binding of p65 to the IL-8 promoter was examined 
using the chromatin immunoprecipitation assay.
re s u l t s: ZnO exposure (2−8 µg/mL) increased IL-8 mRNA and protein expression. Inhibition of 
transcription with actinomycin D blocked ZnO­induced IL-8 expression, which was consistent with 
the observation that ZnO exposure increased IL-8 promoter reporter activity. Further study demon­
strated that the κB­binding site in the IL-8 promoter was required for ZnO­induced IL-8 tran­
scriptional activation. ZnO stimulation modestly elevated IκBα phosphorylation and degradation.   
Moreover, ZnO exposure also increased the binding of p65 to the IL-8 promoter and p65 
phosphoryla  tion at serines 276 and 536. Overexpression of p65 constructs mutated at serines 276 
or 536 significantly reduced ZnO­induced increase in IL-8 promoter reporter activity.
co n c l u s i o n: p65 phosphorylation and IκBα phosphorylation and degradation are the primary 
mechanisms involved in ZnO nano  particle­induced IL-8 expression in human bronchial epithelial 
cells.
key w o r d s : bronchial epithelial cells, IL­8, interleukin­8, NFκB, p65, zinc oxide. Environ Health 
Perspect 118:982–987 (2010).  doi:10.1289/ehp.0901635 [Online 1 March 2010]Regulation of ZnO−induced IL-8 expression
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ZnO­induced IL‑8 expression in human bron­
chial epithelial cells.
Materials and Methods
Materials and reagents. We purchased ZnO 
(99% purity, 24–70 nm in diameter) from 
Alfa Aesar (Ward Hill, MA); Triton X­100 
and poly  acrylamide from Sigma Chemical Co. 
(St. Louis, MO); and SDS­PAGE (sodium 
dodecyl sulfate poly  acrylamide gel electropho­
resis) supplies, such as molecular mass stan­
dards and buffers, from Bio­Rad (Richmond, 
CA). We obtained anti­human p65 poly­
clonal antibody from Cayman Chemical (Ann 
Arbor, MI); phospho­specific rabbit anti­
bodies against human NFκB p65 [serine 276 
(Ser276), serine 536 (Ser536)] and human 
IκBα [serine 32 (Ser32)] from Cell Signaling 
Technology (Beverly, MA); β­actin antibody 
from USBiological (Swampscott, MA); and 
IκBα antibody and horseradish peroxidase 
(HRP)­conjugated goat anti­rabbit anti­
body from Santa Cruz Biotechnology (Santa 
Cruz, CA). Actinomycin D (Act D) was pur­
chased from EMD Biosciences, Inc. (San 
Diego, CA); the IL­8 ELISA (enzyme­linked 
immuno  sorbent assay) kit and the recombi­
nant TNFα were purchased from eBioscience 
(San Diego, CA); the FuGENE 6 transfection 
reagent was obtained from Roche Diagnostics 
Corporation (Indianapolis, IN); and chemi­
luminescence reagents were obtained from 
Pierce Biotechnology (Rockford, IL).
Cell culture and exposure. Primary human 
bronchial epithelial cells. According to a pro­
tocol approved by the University of North 
Carolina Institutional Review Board, cells 
were obtained by cytologic brushing during 
bronchoscopy from healthy non  smoking adult 
volun  teers who had given informed consent; 
cells were frozen in liquid nitrogen until use. 
After thawing, the human bronchial epithe­
lial cells were expanded to passage 2 in bron­
chial epithelial growth medium (Cambrex 
Bioscience Walkersville, Inc., Walkersville, 
MD), then plated on collagen­coated filter 
supports with a 0.4­µm pore size (Trans­CLR; 
Costar, Cambridge, MA) to undergo air liq­
uid interface (ALI) culture in a 1:1 mixture 
of bronchial epithelial cell basic medium 
and Dulbecco’s modified Eagle’s medium­H 
with SingleQuot supplements (Cambrex), 
bovine pituitary extract (13 mg/mL),   
bovine serum albumin (1.5 µg/mL), and nys­
tatin (20 units). Upon confluency, all‑trans 
retinoic acid was added to the medium, and 
ALI culture conditions (removal of the apical 
medium) were created to promote differen­
tiation. ZnO nano  particles were suspended in 
molecular­grade water. Because ZnO nano­
particles were poorly dissolved in water, the 
ZnO suspension was sonicated before being 
added to the apical surface of the ALI culture 
for stimulation.
BEAS­2B cell line. The BEAS­2B cell line 
was derived by transforming human bron­
chial cells with an adenovirus 12­simian 
virus 40 construct (Reddel et al. 1988). We 
obtained BEAS­2B cells from the American 
Type Culture Collection (ATCC, Manassas, 
VA). BEAS­2B cells (passages 70–80) were 
grown on tissue culture–treated Costar plates 
in keratinocyte basal medium supplemented 
with 30 µg/mL bovine pituitary extract,   
5 ng/mL human epidermal growth factor, 500 
ng/mL hydrocortisone, 0.1 mM ethanol  amine, 
0.1 mM phospho  ethanolamine, and 5 ng/mL 
insulin. A suspension of ZnO was added to 
the surface of confluent BEAS­2B cells for 
stimulation. The doses of ZnO nano  particles 
used in this study ranged from 2 to 8 µg/mL.
Real-time reverse transcriptase/polymerase 
chain reaction (RT-PCR). Bronchial epithe­
lial cells grown to confluence were exposed to 
ZnO. Cells were washed with ice­cold phos­
phate­buffered saline (PBS) and then lysed with 
TRIZOL reagent (Invitrogen Corporation, 
Carlsbad, CA). Total RNA (100 ng), 
0.5 mM nucleoside tri  phosphate (Pharmacia, 
Piscataway, NJ), 5 µM random hexa  oligo­
nucleotide primers (Pharmacia), 10 U/µL 
RNase inhibitor (Promega, San Luis Obispo, 
CA), and 10 U/µL Moloney murine leukemia 
virus RT (GIBCO­BRL Life Technologies, 
Gaithersburg, MD) were incubated in a 40°C 
water bath for 1 hr in 50 µL 1× PCR buf­
fer to synthesize first­strand cDNAs. The 
reverse transcription was inactivated by heat­
ing at 92°C for 5 min. Quantitative PCR of 
IL‑8 and glyceraldehyde­3­phosphate dehy­
drogenase (GAPDH) specimen cDNA and 
standard cDNA was performed in a 50­µL 
final volume mixture containing TaqMan 
master mix (PerkinElmer, Foster City, CA), 
1.25 µM probe, 3 µM forward primer, and 
3 µM reverse primer. The probe annealed to 
the template between the two primers. This 
probe contained both a fluorescence reporter 
dye at the 5´ end (6­carboxy  fluorescein: emis­
sion λmax = 518 nm) and a quencher dye at 
the 3´ end (6­carboxy  tetramethyl rhodamine: 
emission λmax = 582 nm). During polymeriza­
tion, the probe was degraded by the 5´–3´ exo­
nuclease activity of the Taq DNA polymerase, 
and the fluorescence was detected by a laser 
in the sequence detector (TaqMan ABI Prism 
7700 Sequence Detector System; PerkinElmer). 
Thermal cycler parameters included 2 min at 
50°C, 10 min at 95°C, and 40 cycles of dena­
turation at 95°C for 15 sec and annealing/
extension at 60°C for 1 min. Relative amounts 
of IL‑8 and GAPDH mRNA were based on 
standard curves prepared by serial dilution of 
cDNA from human BEAS­2B cells. The oligo­
nucleotide primers and probes were purchased 
from Applied Biosystems (Foster City, CA).
ELISA. We assayed IL­8 protein in the 
cell culture supernatant using with a human 
IL­8 ELISA kit according to the manufac­
turer’s instructions.
Immunoblotting. BEAS­2B cells were 
treated with ZnO suspension, washed twice 
with ice­cold PBS, then lysed in RIPA buffer 
[1× PBS, 1% nonidet P­40, 0.5% sodium 
deoxy  cholate, 0.1% SDS, and protease inhib­
itors (20 µg/mL leupeptin, 20 µg/mL aproti­
nin, 0.5 mM phenylmethylsulfonyl fluoride, 
200 µM sodium orthovanadate, and 20 mM 
sodium fluoride)]. Supernatants of cell lysates 
were subjected to SDS­PAGE. Proteins were 
transferred onto nitro  cellulose membrane. The 
membrane was blocked with 5% nonfat milk, 
washed briefly, and incubated with primary 
antibody at 4°C overnight, followed by incu­
bation with corresponding HRP­conjugated 
secondary antibody for 1 hr at room tem­
perature. Immuno  blot images were detected 
using chemiluminescence reagents and the 
Gene Gynome Imaging System (Syngene, 
Frederick, MD).
Chromatin immunoprecipitation (ChIP) 
assay. We conducted the ChIP assay using a 
ChIP kit (Upstate, Lake Placid, NY). Briefly, 
BEAS­2B cells growing in 100­mm dishes 
were treated with ZnO for 2 hr before being 
subjected to cross­linking with 1% formalde­
hyde at 37°C for 10 min. After washing with 
PBS, the cells were resuspended in 300 µL lysis 
buffer [50 mM Tris­HCl (pH 8.1), 10 mM 
EDTA, 1% SDS, protease inhibitor cocktail]. 
DNA was sheared to 200–1,000 base pair 
small fragments by sonication. The superna­
tant was recovered, diluted, and precleared 
using salmon sperm DNA/protein A agarose. 
The recovered supernatant was incubated with 
anti­p65 antibody or an isotype control IgG 
for 2 hr in the presence of salmon sperm DNA 
and protein G­Sepharose beads. The beads 
were washed with low­salt, high­salt, and lith­
ium chloride buffers. The immuno  precipitated 
DNA was retrieved from the beads with 1% 
SDS and 0.1 mM NaHCO3 solution at 65°C 
for 4 hr, then purified with a QIAquick spin 
column (Qiagen, Valencia, CA). The PCR was 
conducted on the extracted DNA using IL‑8 
promoter­specific primers at 95°C for 2 min, 
followed by 35 cycles of 95°C for 30 sec, 55°C 
for 30 sec, and 72°C for 30 sec. The PCR 
products were separated on a 1.4% agarose gel 
and stained with ethidium bromide.
Transient gene transfection. BEAS­2B cells 
grown to 40–50% confluence were transfected 
with the specific constructs for 24 hr using 
FuGENE 6 transfection reagent according 
to manufacturer’s instructions. These con­
structs included luciferase­conjugated IL‑8 
promoter (p1.5IL‑8­luc), κB binding­site–
mutated IL‑8 promoter (p1.5IL‑8­κB­luc), 
the five tandem repeat of NFκB response ele­
ment (pNFκB­luc), and Flag­p65, Flag­p65 
S276A, and FLAG­p65 S536A (Kim et al. 
2007). The pSV­β­galactosidase construct was Wu et al.
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co­transfected with the individual construct 
depicted previously as an internal control (Kim 
et al. 2007). After transfection, the cells were 
incubated with keratinocyte basal medium 
overnight and then treated with ZnO before 
being lysed with lysis buffer. We detected 
luciferase and β­galactosidase activities using 
the Dual­Light chemiluminescent reporter 
gene assay system (Tropix, Bedford, MA) and 
an AutoLumat LB953 luminometer (Berthold 
Analytical Instruments, Nashua, NH). 
Luciferase activity was estimated as luciferase 
count/β­galactosidase count (luc/gal).
Statistical analysis. Data are presented as 
mean ± SE. Data were evaluated using non­
parametric paired t­tests with the overall α level 
set at 0.05. One­way analysis of variance was 
used to analyze the time­ and dose­dependent 
trends of IL‑8 mRNA and protein expression.
Results
ZnO exposure increases IL­8 expression in 
human bronchial epithelial cells. To exam­
ine the effect of ZnO nano  particles on IL‑8 
expression in human bronchial epithelial 
cells, we used ALI­cultured primary human 
bronchial epithelial cells and BEAS­2B cells. 
As shown in Figure 1A, exposure of ALI­
cultured primary human bronchial epithe­
lial cells to 8 µg/mL ZnO for 4 hr induced 
a significant increase in IL‑8 mRNA levels. 
In BEAS­2B cells, ZnO stimulation (8 µg/
mL) induced a time­dependent increase in 
IL‑8 mRNA expression (F = 47.24; p < 0.01). 
Exposure of BEAS­2B cells to ZnO for 4 hr 
caused a dose­dependent increase in IL‑8 
mRNA expression (Figure 1C; F = 41.83, 
p < 0.01). In addition, ZnO exposure resulted 
in a dose­dependent increase in IL­8 protein 
release from BEAS­2B cells after a 6­hr expo­
sure (Figure 1D; F = 96.14, p < 0.01). These 
results indicate that ZnO exposure up­regu­
lates IL‑8 expression at both mRNA and pro­
tein levels in human bronchial epithelial cells.
Transcriptional activation is involved in 
ZnO-induced IL­8 expression. To examine 
the involvement of transcriptional regulation 
in ZnO­induced elevation of IL‑8 mRNA, 
we pre  treated BEAS­2B cells with 10 µg/mL 
Act D, a potent inhibitor of RNA polymerase, 
before treatment with ZnO. Pretreatment with 
Act D for 30 min ablated ZnO­induced IL‑8 
Figure 1. ZnO exposure increases IL‑8 mRNA and protein expression in human bronchial epithelial cells. 
(A) IL‑8/GAPDH mRNA level in ALI-cultured primary human bronchial epithelial cells treated with 2–8 µg/mL 
ZnO, (B) confluent BEAS-2B cells treated with 8 µg/mL ZnO for 2 hr or 4 hr, and (C) confluent BEAS-2B cells 
treated with 2, 4, or 8 µg/mL ZnO for 4 hr. IL‑8 mRNA levels were determined by RT-PCR. (D) IL-8 protein in 
BEAS-2B cells treated with 4 or 8 µg/mL ZnO for 6 hr; assayed protein content was determined using ELISA. 
Data shown are representative of three separate experiments. 
*p < 0.05 compared with 0 µg/mL ZnO.
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Figure 2. Transcriptional regulation is involved in ZnO-induced IL‑8 expression. (A) IL‑8/GAPDH mRNA level 
in confluent BEAS-2B cells pretreated with 10 µg/mL Act D for 30 min, then stimulated with 8 µg/mL ZnO 
for 2 hr. Dimethyl sulfoxide served as a vehicle control for Act D. IL‑8 mRNA levels were determined by 
RT-PCR. (B) IL‑8 promoter reporter activity in BEAS-2B cells grown to 40–50% confluence and transfected 
with p1.5IL‑8‑luc and pSV-β-galactosidase constructs using FuGENE 6 transfection reagent. Twenty-four 
hours after transfection, cultures were incubated with keratinocyte basal medium overnight; the cells were 
then treated with 8 µg/mL ZnO for 6 hr before being lysed. Luciferase activity was estimated as luciferase 
count/β-galactosidase count (luc/gal). Data shown are representative of three separate experiments. 
*p < 0.05 compared with DMSO plus ZnO. **p < 0.05 compared with 0 µg/mL ZnO.
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Figure 3. ZnO exposure induces NFκB activation in 
BEAS-2B cells. (A) Phosphorylation of IκBα in cells 
pretreated with 20 µM MG132 for 30 min (to prevent 
IκBα degradation) before further stimulation with 
8 µg/mL ZnO for 15, 30, 60, or 120 min, or 100 ng/mL 
TNFα for 30 min; cell lysates were separated by 
SDS-PAGE and immunoblotted with anti-phospho-
IκBα (Ser32/36) and anti-IκBα antibodies. (B) IκBα 
degradation in cells treated with 8 µg/mL ZnO for 15, 
30, 60, or 120 min, or 100 ng/mL TNFα for 30 min; cell 
lysates were separated by SDS-PAGE and immuno-
blotted with anti-IκBα and anti-actin antibodies. 
(C) NFκB reporter activity, estimated as luciferase 
count/β-galactosidase count, in cells grown to 
40–50% confluence, transfected with pNFκB-luc 
and p-SV‑β‑galactosidase constructs, and treated 
with 8 µg/mL ZnO for 6 hr. Data shown are represen-
tative of three separate experiments.
*p < 0.05 compared with 0 µg/mL ZnO. 
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mRNA (Figure 2A), suggesting that transcrip­
tional regulation was required for IL‑8 expres­
sion in ZnO­exposed cells. To confirm this 
observation, we measured the IL‑8 promoter 
activity through transient gene transfection of a 
luciferase­conjugated IL‑8 promoter construct. 
As predicted by the Act D results, ZnO expo­
sure (8 µg/mL) significantly increased IL‑8 pro­
moter reporter activity (Figure 2B). These data 
indicate that ZnO­induced IL‑8 gene expres­
sion in human bronchial epithelial cells occurs 
through a transcriptional mechanism.
ZnO exposure induces NFκB activation. 
Activation of the transcription factor NFκB 
is required for IL‑8 gene transcription activa­
tion in many cell types (Villarete and Remick 
1996). To examine whether ZnO stimula­
tion increased NFκB activity, we deter­
mined phosphorylation and degradation of 
the NFκB inhibitory protein κBα (IκBα), 
an event indicative of the canonical NFκB­
activating pathway (Ghosh and Karin 2002; 
Karin and Ben­Neriah 2000). In BEAS­2B 
cells exposed to 8 µg/mL ZnO for 15, 30, 60, 
or 120 min, we measured phosphorylation of 
IκBα on Ser32. As shown in Figure 3A, expo­
sure to ZnO (after pretreatment with the pro­
teasome inhibitor MG132) induced a modest 
phosphorylation of IκBα, which peaked at 
15­min exposure and declined thereafter. As 
expected, TNFα (100 ng/mL), the positive 
IκBα phosphorylation inducer, increased 
IκBα phosphorylation at 30 min exposure. 
In a manner consistent with this observation, 
ZnO stimulation in the absence of MG132 
caused IκBα degradation at 30 min exposure 
to ZnO (Figure 3B). These data indicated that 
ZnO exposure can induce modest canonical 
NFκB activation in BEAS­2B cells. To fur­
ther confirm ZnO­induced NFκB activation, 
BEAS­2B cells were transiently transfected 
with pNFκB­luc and p­SV­β‑galactosidase 
constructs prior to ZnO treatment. As shown 
in Figure 3C, ZnO exposure (8 µg/mL) 
increased NFκB reporter activity at 6 hr of 
exposure, demonstrating that ZnO treatment 
increases NFκB­dependent transcriptional 
activity.
NFκB is required for ZnO-induced IL­8 
expression. To further determine whether 
NFκB was involved in ZnO­induced IL‑8 
gene transcription, we transfected BEAS­2B 
cells with luciferase­conjugated IL‑8 promoter 
(p1.5IL‑8­luc) and κB binding site–mutated 
IL‑8 promoter (p1.5IL‑8­κB­luc) constructs, 
respectively, prior to treatment with 8 µg/mL   
ZnO for 6 hr. As shown in Figure 4, the 
luciferase reporter activity induced by ZnO 
stimulation was significantly reduced in the 
cells expressing κB binding site–mutated IL‑8 
promoter compared with that in the cells 
expressing the intact (wild­type) IL‑8 pro­
moter, implying that NFκB is required for 
ZnO­induced IL‑8 gene transcription.
Phosphorylation of p65 NFκB mediates 
ZnO-induced IL­8 mRNA expression. NFκB 
exerts its regulatory function through binding 
specific DNA sequences as homo­ or hetero­
dimers composed of members of the Rel/
NFκB family (Hayden and Ghosh 2004). 
The most ubiquitous NFκB complex is the 
hetero  dimer p50/p65(RelA). We investigated 
whether p65 NFκB could bind to the IL‑8 
gene promoter in ZnO­treated BEAS­2B cells 
incubated with 8 µg/mL ZnO for 2 hr. Cell 
lysates were then subjected to the ChIP assay 
using anti­p65 and isotype control anti  bodies. 
As shown in Figure 5A, ZnO stimulation 
resulted in a marked increase in the binding 
of p65 NFκB to the IL‑8 gene promoter.
Phosphorylation of specific serine residues 
of the p65 NFκB subunit has been shown 
to be important for its transcriptional activ­
ity (Okazaki et al. 2003). Therefore, we used 
phospho­specific anti  bodies to meas  ure the 
phosphorylation of p65 NFκB at ser276 and 
ser536 in BEAS­2B cells exposed to ZnO. We 
observed that ZnO treatment induced a rapid 
increase in phosphorylation of p65 at both 
serine residues (Figure 5B). Phosphorylation 
of p65 (Ser536) in ZnO­treated cells occurred 
as early as 15 min exposure and was decreased 
at 60 min. In contrast, phosphorylation levels 
of p65 (Ser276) went up more slowly but were 
still above the control level at 60 min. These 
data indicated that ZnO exposure increased 
p65 phosphorylation in human bronchial 
  epithelial cells.
To determine the functional importance 
of p65 phosphorylation in ZnO­induced 
IL‑8 gene transcription, we co­transfected 
BEAS­2B cells with p1.5IL‑8­luc and either a 
wild­type p65 construct or a mutated version 
in which either Ser276 or Ser536 in p65 was 
mutated. As expected, ZnO exposure induced 
increased IL‑8 promoter reporter activity in 
cells expressing wild­type p65 (Figure 5C). 
In comparison with the cells expressing wild­
type p65, the cells that expressed mutated p65 
showed a significant reduction in IL‑8 pro­
moter reporter activity after ZnO treatment. 
These data strongly suggest that phosphoryla­
tion of p65 is required for ZnO­induced IL‑8 
gene transcription.
Discussion and Conclusion
Cellular responses to environmental stimuli 
require rapid and accurate transmission of sig­
nals from cell­surface receptors to the nucleus 
(Karin and Hunter 1995). These signaling 
pathways rely on protein phosphorylation and, 
ultimately, lead to the activation of specific 
transcription factors that induce the expres­
sion of appropriate target genes. In the present 
study using human bronchial epithelial cells, 
we have demonstrated that exposure to the 
Figure 4. NFκB is required for ZnO-induced IL‑8 
gene transcription, as shown by luciferase activ-
ity. BEAS-2B cells grown to 40–50% confluence 
were transfected with p1.5IL‑8-luc (IL‑8 wild-type) 
or p1.5IL‑8-κB-luc (IL‑8 mutant), as described in 
“Materials and Methods,” prior to treatment with 
8 µg/mL ZnO for 6 hr. Data shown are representa-
tive of three separate experiments.
*p < 0.05 compared with ZnO treatment in the IL‑8 wild-type 
group.
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ZnO nano  particles induces IL‑8 gene expres­
sion by activating NFκB through a bimodal 
mechanism that involves p65 NFκB phospho­
rylation as well as IκBα phosphorylation and 
degradation.
Increased expression of IL­8 protein is 
largely dependent on transcriptional activa­
tion of the IL‑8 gene (Wickremasinghe et al. 
1999). This is corroborated by the results of 
the present study, which show that pretreat­
ment of BEAS­2B cells with the transcrip­
tional inhibitor Act D abrogated ZnO­induced 
IL‑8 mRNA expression as well as the activa­
tion of IL‑8 promoter activity in ZnO­treated 
cells. The NFκB family of transcription fac­
tors is essential for inflammation, immunity, 
and cell proliferation. Five members of the 
NFκB family have been identified: NFκB1 
(p50/p105), NFκB2 (p52/p100), RelA (p65), 
RelB, and c­Rel. They share a highly conserved 
Rel homology domain at the N­terminal end 
that is responsible for specific DNA binding, 
dimerization, and interaction with IκB. In 
addition, some Rel proteins such as p65 (RelA) 
contain one or two C­terminal transactivating 
domain. In mammals, the NFκB transcription 
factor consists of two subunits of either homo­ 
or hetero  dimers of RelA/p65, c­Rel, and p50. 
The p50/RelA(p65) heterodimer is the major 
Rel/NFκB complex in most cell types (Gilmore 
1999). In resting cells, NFκB complexes are 
sequestered in an inactive form in the cyto­
plasm of the cells through its association with 
an inhibitory protein belonging to the IκB 
family, IκBα being the prototype. Upon cell 
stimulation, IκBα is phosphorylated by one of 
a number of IκB kinases, ubiquitinylated, and 
degraded, thereby allowing the NFκB complex 
to translocate into the nucleus and regulate 
the expression of its target genes, such as those 
coding for cytokines, adhesion molecules, and 
chemo  kines that have a crucial role in both 
immune and inflammatory responses (Hayden 
and Ghosh 2004; Karin and Ben­Neriah 2000; 
Rossi and Zlotnik 2000). Our data show that 
ZnO exposure induces rapid phosphorylation 
and degradation of IκBα, consistent with an 
increase in NFκB transcriptional activity and 
ensuing IL‑8 gene transcription. However, the 
modest degree of phosphorylation and degra­
dation of IκBα induced by ZnO stimulation 
implied that other events might also partici­
pate in ZnO­induced NFκB transcriptional 
activation.
Increasing evidence from biochemi­
cal and genetic experiments strongly suggests 
that optimal induction of NFκB target genes 
also requires posttranslational modifications 
of NFκB p65 (Perkins 2006; Schmitz et al. 
2004). For example, the acetylation of p65 has 
been proposed to facilitate the retention of the 
NFκB complex in the nucleus (Ashburner et al. 
2001; Chen et al. 2001). The phosphorylation 
of p65 can result in a conformational change 
that increases its DNA binding activity and 
ability to recruit histone acetyltransferases such 
as cAMP response element­binding (CREB)­
binding protein and p300 and to displace p50–
histone deacetylase­1 complexes from DNA, 
leading to increased transcriptional activity 
(Ashburner et al. 2001; Chen et al. 2001). The 
NFκB p65 can be phosphorylated at multiple 
sites either in the N­terminal Rel homology 
domain or C­terminal transa  ctivating domain 
(Viatour et al. 2005). The best­characterized 
phosphorylated residues on p65 are Ser276 and 
Ser536. In the present study, we observed that 
ZnO exposure increased the binding of p65 to 
the IL‑8 gene promoter and also increased the 
phosphorylation of p65 at Ser276 and Ser536 
in BEAS­2B cells. Previous studies have shown 
that p65 can be phosphorylated by a variety 
of cytoplasmic and nuclear kinases in a stimu­
lus­ and cell type­specific manner (Jamaluddin 
et al. 2007; Schmitz et al. 2004; Viatour et al. 
2005; Zhong et al. 2002). Further study will be 
required to elucidate the mechanisms responsi­
ble for ZnO­induced phosphorylation of p65.
The role of particle dissolution in ZnO­
induced toxic effects has been investigated; 
however, the results differ with particle size 
and cell types. A study using human aortic 
endothelial cells showed that ZnO nano­
particles (20–70 nm diameter) can be inter­
nalized into cells and that ZnO­induced 
inflammatory response is due to the presence 
of the particles rather than ZnO­released Zn2+ 
(Gojova et al. 2007). In contrast, a recent 
study using Raw264.7 cells and BEAS­2B 
cells proposed that the toxicity of ZnO nano­
particles (13 nm) in both cell types is related 
to particle dissolution that could happen in 
culture medium and intracellular endosomes 
(Xia et al. 2008). In separate experiments 
(data not shown) we observed that ZnO par­
ticles were poorly dissolved in water and that 
the phago  cytosis inhibitor cyto  chalasin D 
partially blocked ZnO­induced IL‑8 expres­
sion in BEAS­2B cells, implying that ZnO 
particle internalization and subsequent disso­
lution may be involved in ZnO­induced IL‑8 
expression.
Human inhalation studies have shown 
that exposure to ZnO in welding fumes 
induced early increase in TNFα protein con­
centration and subsequent elevation of IL­8 
and IL­6 protein levels in broncho  alveolar 
lavage fluid (Blanc et al. 1993; Kuschner et al. 
1997). Moreover, TNFα has been shown to 
induce IL­8 production from BEAS­2B cells 
(Fujisawa et al. 2000). These observations 
lead to an assumption that ZnO­induced 
IL‑8 expression may be mediated through an 
autocrine mechanism that involves TNFα. 
However, we have observed that TNFα­
neutralizing antibody had minimal inhibi­
tory effect on ZnO­induced IL‑8 mRNA and 
protein expression even though it blocked 
TNFα­induced IL‑8 mRNA expression 
by > 90% (data not shown), implying that 
TNFα is not involved in ZnO­induced IL‑8 
expression in BEAS­2B cells.
ZnO usually exists in the form of ultra­
fine particles in ambient and workplace air; 
thus, exposure to ZnO particles is associated 
with adverse effects in environmental and 
occupational settings. Characterization of the 
under  lying mechanisms of ZnO toxicity may 
provide helpful information in the prevention 
and treatment of pulmonary and systemic dis­
orders related to inhalation of ultrafine ZnO 
particles.
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